Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 315.00
Bid: 317.00
Ask: 320.00
Change: 3.50 (1.12%)
Spread: 3.00 (0.946%)
Open: 310.00
High: 317.50
Low: 310.00
Prev. Close: 311.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block Listing Return

2 Jan 2024 07:00

RNS Number : 2617Y
Oxford Biomedica PLC
02 January 2024
 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Employee Share Option Scheme

Period of return:

From:

1 July 2023

To:

31 December 2023

Balance of unallotted securities under scheme(s) from previous return:

309,426

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

2,905

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

306,521

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Long Term Incentive Plan

Period of return:

From:

1 July 2023

To:

31 December 2023

Balance of unallotted securities under scheme(s) from previous return:

442,977

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

192,609

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

250,368

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

2015 Deferred Bonus Plan

Period of return:

From:

1 July 2023

To:

31 December 2023

Balance of unallotted securities under scheme(s) from previous return:

296,272

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

28,200

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

268,072

 

 

 

Name of applicant:

OXFORD BIOMEDICA PLC

Name of scheme:

Sharesave Scheme

Period of return:

From:

1 July 2023

To:

31 December 2023

Balance of unallotted securities under scheme(s) from previous return:

339,753

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

NIL

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

NIL

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

339,753

 

Name of contact:

Natalie Walter, Company Secretary

Telephone number of contact:

01865 783000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRTLBFTMTITBBJ
Date   Source Headline
17th Jan 20144:35 pmRNSPrice Monitoring Extension
10th Jan 20147:00 amRNSPublication of ProSavin Phase I/II Study
9th Jan 201412:19 pmRNSOxford BioMedica to Present at Biotech Showcase
6th Jan 201410:28 amRNSOxford Biomedica PLC - General Meeting
18th Dec 20137:00 amRNSOXB option agreement with GSK
11th Dec 20137:00 amRNSCIRCULAR & GENERAL MEETING NOTIFICATION
22nd Nov 201312:38 pmRNSDirector/PDMR Shareholding
19th Nov 20137:00 amRNS£5 million Loan Facility from Lead Shareholder
19th Nov 20137:00 amRNSInterim Management Statement
17th Oct 20137:00 amRNSAgreement to Resume Clinical Trials
19th Sep 20137:00 amRNSDirector/PDMR Shareholding
17th Sep 20131:06 pmRNSBlock Listing Return
12th Sep 201311:18 amRNSOxford BioMedica plc Director's Share Purchase
11th Sep 20131:01 pmRNSOxford BioMedica Wins Significant Funding
6th Sep 20134:40 pmRNSSecond Price Monitoring Extn
6th Sep 20134:35 pmRNSPrice Monitoring Extension
29th Aug 20134:08 pmRNSTR1 Form
29th Aug 20137:00 amRNSInterim Results 2013
28th Aug 20137:00 amRNSUS$1 million Milestone Payment from Pfizer
14th Aug 20131:00 pmRNSAnnounced as Funding Competition Winner
29th Jul 20137:00 amRNSPublication of TroVax Phase II Analyses
23rd Jul 20137:00 amRNSNotice of Interim Results
16th Jul 201311:20 amRNSDirector/PDMR Shareholding
1st Jul 20137:00 amRNSUpdate on Glaucoma-GT
28th Jun 20137:00 amRNSTotal Voting Rights
20th Jun 201311:15 amRNSDirector/PDMR Shareholding
19th Jun 201311:00 amRNSTR-1: Notification of Major Interest in Shares
12th Jun 20137:00 amRNSDirectors' Interests in Share Options
10th Jun 201312:59 pmRNSDirector/PDMR Shareholding
10th Jun 201312:59 pmRNSTR-1: Notification of Major Interest in Shares
10th Jun 20137:00 amRNSDirector's Share Purchase
6th Jun 201311:45 amRNSResult of AGM
6th Jun 20137:00 amRNSChange of Adviser and Broker
6th Jun 20137:00 amRNSManagement and Board change
5th Jun 201310:43 amRNSTR-1: Notification of Major Interest in Shares
3rd Jun 20137:00 amRNSClinical Trial Update
24th May 201310:00 amRNSBLOCK LISTING RETURN
16th May 20137:00 amRNSInterim Management Statement
9th May 20139:00 amRNSUpdate from ARVO 2013
3rd May 20132:00 pmRNSHolding(s) in Company
3rd May 20132:00 pmRNSDirector/PDMR Shareholding
1st May 20137:03 amRNSCollaboration with Novartis
17th Apr 20131:00 pmRNS2012 ANNUAL REPORT & ACCOUNTS & AGM NOTIFICATION
7th Mar 20137:00 amRNSInitiation of PII Collaborative Study for TroVax
27th Feb 20137:00 amRNSPreliminary Results
25th Jan 20134:40 pmRNSSecond Price Monitoring Extn
25th Jan 20134:35 pmRNSPrice Monitoring Extension
23rd Jan 20137:00 amRNSNotice of Preliminary Results
29th Nov 20127:00 amRNSExercise of Option by ImaginAb
28th Nov 20127:00 amRNSBlock Listing Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.